These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34142330)

  • 1. Assessment of the Effects of a High Amikacin Dose on Plasma Peak Concentration in Critically Ill Children.
    Medjebeur Hanna R; Levy M; Bille E; Hennequin C; Lesage F; Naudin J; Moulin F; Blanquer M; Béranger A; Renolleau S; Oualha M; Genuini M
    Paediatr Drugs; 2021 Jul; 23(4):395-401. PubMed ID: 34142330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.
    de Montmollin E; Bouadma L; Gault N; Mourvillier B; Mariotte E; Chemam S; Massias L; Papy E; Tubach F; Wolff M; Sonneville R
    Intensive Care Med; 2014 Jul; 40(7):998-1005. PubMed ID: 24687298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of amikacin pharmacokinetic/pharmacodynamic index on treatment response in critically ill patients.
    Ruiz J; Ramirez P; Company MJ; Gordon M; Villarreal E; Concha P; Aroca M; Frasquet J; Remedios-Marqués M; Castellanos-Ortega Á
    J Glob Antimicrob Resist; 2018 Mar; 12():90-95. PubMed ID: 29017888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of amikacin first peak concentration in critically ill patients.
    Boidin C; Jenck S; Bourguignon L; Torkmani S; Roussey-Jean A; Ledochowski S; Marry L; Ammenouche N; Dupont H; Marçon F; Allaouchiche B; Bohé J; Lepape A; Goutelle S; Friggeri A
    Fundam Clin Pharmacol; 2018 Dec; 32(6):669-677. PubMed ID: 29660162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize
    Boidin C; Bourguignon L; Cohen S; Roger C; Lefrant JY; Roberts JA; Allaouchiche B; Lepape A; Friggeri A; Goutelle S
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations.
    Roger C; Nucci B; Molinari N; Bastide S; Saissi G; Pradel G; Barbar S; Aubert C; Lloret S; Elotmani L; Polge A; Lefrant JY; Roberts JA; Muller L
    Int J Antimicrob Agents; 2015 Jul; 46(1):21-7. PubMed ID: 25857948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation.
    Touchard C; Aubry A; Eloy P; Bréchot N; Lebreton G; Franchineau G; Besset S; Hékimian G; Nieszkowska A; Leprince P; Luyt CE; Combes A; Schmidt M
    Crit Care; 2018 Aug; 22(1):199. PubMed ID: 30121083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of higher doses of amikacin in early stages of sepsis in critically ill patients.
    Najmeddin F; Ahmadi A; Mahmoudi L; Sadeghi K; Khalili H; Ahmadvand A; Najafi A; Mojtahedzadeh M
    Acta Med Iran; 2014; 52(9):703-9. PubMed ID: 25325208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating amikacin dosage regimens in intensive care unit patients: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
    Zazo H; Martín-Suárez A; Lanao JM
    Int J Antimicrob Agents; 2013 Aug; 42(2):155-60. PubMed ID: 23756322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of amikacin in patients with pediatric cystic fibrosis.
    Caceres Guido P; Perez M; Halac A; Ferrari M; Ibarra M; Licciardone N; Castaños C; Gravina LP; Jimenez C; Garcia Bournissen F; Schaiquevich P
    Pediatr Pulmonol; 2019 Nov; 54(11):1801-1810. PubMed ID: 31402602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic/pharmacodynamic evaluations of amikacin dosing in critically ill patients undergoing continuous venovenous hemodiafiltration.
    Li S; Zhu S; Xie F
    J Pharm Pharmacol; 2023 Apr; 75(4):515-522. PubMed ID: 36847263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis.
    Yu T; Stockmann C; Healy DP; Olson J; Wead S; Neely AN; Kagan RJ; Spigarelli MG; Sherwin CM
    J Burn Care Res; 2015; 36(4):e244-52. PubMed ID: 25185930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Ceftriaxone Dose Recommendations are Adequate for Most Critically Ill Children: Results of a Population Pharmacokinetic Modeling and Simulation Study.
    Hartman SJF; Upadhyay PJ; Hagedoorn NN; Mathôt RAA; Moll HA; van der Flier M; Schreuder MF; Brüggemann RJ; Knibbe CA; de Wildt SN
    Clin Pharmacokinet; 2021 Oct; 60(10):1361-1372. PubMed ID: 34036552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical audit of gentamicin use by Bayesian pharmacokinetic approach in critically ill children.
    Sridharan K; Al Daylami A
    J Infect Chemother; 2020 Jun; 26(6):540-548. PubMed ID: 32070645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amikacin pharmacokinetic/pharmacodynamic in intensive care unit: a prospective database.
    Logre E; Enser M; Tanaka S; Dubert M; Claudinon A; Grall N; Mentec H; Montravers P; Pajot O
    Ann Intensive Care; 2020 Jun; 10(1):75. PubMed ID: 32514769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute kidney injury during vancomycin therapy in critically ill children.
    Totapally BR; Machado J; Lee H; Paredes A; Raszynski A
    Pharmacotherapy; 2013 Jun; 33(6):598-602. PubMed ID: 23526674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.
    Carrié C; Delzor F; Roure S; Dubuisson V; Petit L; Molimard M; Breilh D; Biais M
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.
    Hartman SJF; Brüggemann RJ; Orriëns L; Dia N; Schreuder MF; de Wildt SN
    Clin Pharmacokinet; 2020 Feb; 59(2):173-205. PubMed ID: 31432468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic analysis of amikacin twice and single daily dosage in immunocompromised pediatric patients.
    Krivoy N; Postovsky S; Elhasid R; Ben Arush MW
    Infection; 1998; 26(6):396-8. PubMed ID: 9861567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.